UBS Group AG - WINDTREE THERAPEUTICS INC ownership

WINDTREE THERAPEUTICS INC's ticker is WINT and the CUSIP is 97382D105. A total of 27 filers reported holding WINDTREE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of WINDTREE THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$10,000
-28.6%
8,444
-21.7%
0.00%
Q4 2016$14,000
-65.9%
10,784
-33.4%
0.00%
Q3 2016$41,000
+32.3%
16,193
+1.8%
0.00%
Q2 2016$31,00015,9000.00%
Other shareholders
WINDTREE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 777,797$972,0000.11%
SABBY MANAGEMENT, LLC 334,414$415,0000.02%
Summit Financial Wealth Advisors, LLC 13,000$16,0000.01%
Alyeska Investment Group, L.P. 464,769$581,0000.01%
Baker Brothers Advisors 254,973$319,0000.00%
Acrospire Investment Management LLC 4,800$6,0000.00%
WEDBUSH SECURITIES INC 10,784$13,0000.00%
Alyeska Investment Group, L.P. 178,570$223,0000.00%
A.R.T. Advisors, LLC 16,400$20,0000.00%
UBS Group AG 10,784$14,0000.00%
View complete list of WINDTREE THERAPEUTICS INC shareholders